An Intrinsic Capacity Identification and Management Programme for Older Adults in Singapore's Primary Care

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-100
SponsorGeriatric Education and Research Institute

About this trial

The IMPACTFrail program is an intrinsic capacity (IC) identification and management program for mildly frail older adults. Specifically, it delivers the three-tier approach recommended in the National Frailty Strategy Policy Report. The program's core functions include the segmentation of older persons using the Clinical Frailty Scale (CFS) score followed by secondary IC screening for CFS 4 to 5 (Tier 1), follow-up clinical assessment to confirm IC losses (Tier 2) and needs-directed management and tracking of their health (Tier 3).

The investigator aims to conduct a multi-site feasibility study on a small group of older adult study participants (n=30 per polyclinic).

The feasibility study has a few components. First, a qualitative study will assess its feasibility (implementation, appropriateness, acceptability, practicality, adaptability) as perceived by older adults, healthcare providers, and healthcare administrators. Second, the investigator aims to collect process indicators to track its implementation progress. Third, program costs will be estimated. Fourth, the investigator will develop a logic model and theory of change, and cluster-specific detailed written program descriptions. Lastly, the investigator aims to triangulate the findings and assess the feasibility for larger-scale implementation. This study is guided by implementation science frameworks and guidelines for conducting feasibility studies.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

being a patient of the polyclinic site

aged 60 years and above

Clinical frailty score (CFS) of 4 - 5

Not done comprehensive geriatric assessment (CGA) in the past 12 months (based on available medical records or self-report)

Disqualifiers

Do not meet inclusion criteria above

aged 21 years and above

Involved in the IMPACTFrail program as an implementer and/or a healthcare administrator with authority to make implementation decisions.

Do not meet inclusion criteria above

Trial population

Older adults will be polyclinic patients aged 60 years and above with CFS score 4 or 5 as assigned by a trained healthcare provider at the polyclinic. They should not have done any comprehensive geriatric assessment or be currently receiving geriatric specialist outpatient services. Healthcare staff can be polyclinic healthcare providers (e.g., polyclinic doctors, nurses, care coordinators, care managers, medical social workers). Healthcare administrators would be from the polyclinic leadership team, who are decision-makers who have the authority to make implementation decisions and are familiar with the overall frailty and IC management strategies in primary care in Singapore.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • The IMPACTFrail programme

    Other intervention

    The IMPACTFrail programme

Treatment groups

180 Participants
are divided into 1 treatment group
Group A: Older Adults (programme recipients)1 intervention

Trial outcomes

Primary outcomes

1

Qualitative study 1

What will be measured: Deviations to the intended execution of the programme and implementation strategies and reasons for changes made. How will it be measured: Via in-depth interviews (IDIs) and focus group discussions (FGDs) with healthcare administrators and healthcare providers. All participants for the qualitative study will be identified through purposive sampling. We will adopt the Rapid Qualitative Inquiry (RQI) approach in data analysis.

Time frame
Mar 2025 - Feb 2026
2

Qualitative study 2

What will be measured: Barriers/facilitators of implementing/receiving the programme and its implementation strategies. How will it be measured: Via in-depth interviews (IDIs) and focus group discussions (FGDs) with healthcare administrators, healthcare providers, and older adults. All participants for the qualitative study will be identified through purposive sampling. We will adopt the Rapid Qualitative Inquiry (RQI) approach in data analysis.

Time frame
Mar 2025 - Feb 2026
3

Qualitative study 3

What will be measured: Perspectives on the ability to deliver innovation with given resources (manpower, infrastructure, IT, others). How will it be measured: Via in-depth interviews (IDIs) and focus group discussions (FGDs) with healthcare administrators and healthcare providers. All participants for the qualitative study will be identified through purposive sampling. We will adopt the Rapid Qualitative Inquiry (RQI) approach in data analysis.

Time frame
Mar 2025 - Feb 2026
4

Qualitative study 4

What will be measured: Suggestions on how to improve the implementation of the programme for scalability and sustainability. How will it be measured: Via in-depth interviews (IDIs) and focus group discussions (FGDs) with healthcare administrators and healthcare providers. All participants for the qualitative study will be identified through purposive sampling. We will adopt the Rapid Qualitative Inquiry (RQI) approach in data analysis.

Time frame
Mar 2025 - Feb 2026

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Geriatric Education and Research Institute

Lead sponsor

National Healthcare Group Polyclinics

Collaborator

National University Polyclinics

Collaborator

SingHealth Polyclinics

Collaborator

This trial is not recruiting at the moment. You can still explore other options: